Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A randomised controlled trial led by Professor Paul Leeson has shown that doctors who use an AI algorithm to assess echocardiograms are more accurate and more confident in their decision making. The study, published in the journal JACC Cardiovascular Imaging, is the first to show that an algorithm can automatically categorise severity of coronary artery disease from a simple echo scan.

Stress echocardiography is one of the most widely used imaging tools to assess coronary artery disease, with clinicians comparing images of how the heart’s wall moves before and after exercise or a pharmacological stressor.  Severe coronary artery disease affects the heart muscle’s ability to contract, and this is visible as changes in how the heart wall moves on an echo scan.

However, these changes need to be spotted ‘by eye’, by a trained and experienced assessor. Different observers for the same echo scan can arrive at different conclusions.

Professor Leeson’s group have therefore been exploring whether automated image assessments using AI can overcome these limitations. But using this in actual clinical practice has been slow, because any tools needs to be very robust and generalizable systems.

The research team therefore developed a bespoke sequence of AI algorithms that could automatically process and extract novel features in a stress echocardiogram. Then, they incorporated these features into a machine learning model, which was trained to distinguish between patients with significant coronary heart disease and those without disease.

To make sure that this machine learning model was working, the researchers tested it on a separate set of echocardiograms, and found that it correctly picked out echocardiograms showing signs of severe coronary heart disease 86% of the time.

Finally, to assess how using the AI algorithm would work in actual clinical practice, the researchers asked four experienced echocardiographers to look through the same echocardiograms that the algorithm had classified. For half of the scans the echocardiographers were provided with a copy of the AI report to help them make a decision. Then, a few months later, they were asked to review the scans again but this time provided with the AI information on the other half of the scans  Each time they reviewed a scan they also indicated how confident they were of their judgement.

The study found that when the echocardiographers had the AI-generated report, they identified 95% of the scans showing coronary artery disease, compared to 85% when they didn’t have AI assistance. Having the AI classifier information also resulted in a 10% increase in self-rated confidence in their judgement, and a 29% decrease in non-confident judgements. 

What really distinguishes this study is that we have tested how an algorithm might operate in actual clinical practice, and we find that it fundamentally changes how doctors make their decisions
- Professor Paul Leeson

The research team have now recruited the first participants for a follow-up randomised trial to run across 15 UK sites over the next 18 months, funded by a multi-million pound grant from the NIHR AI in Healthcare Awards. This follow-up trial is testing the tool prospectively in the clinic and will mean NHS cardiology patients in the trial will, for the first time, receive care guided by the AI.

Read the full study. 

Similar stories

New technology helps decode the genetic changes behind disease

RDM researchers have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Virtual Open Day for Graduate Students 20 October 2026

Join our online session to learn more about preparing a strong application for an RDM graduate course.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulation to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

How body fat is stored across organs may reveal hidden health risks, study suggests

University of Oxford researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

Similar stories

New technology helps decode the genetic changes behind disease

RDM researchers have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

Virtual Open Day for Graduate Students 20 October 2026

Join our online session to learn more about preparing a strong application for an RDM graduate course.

Everyday DNA damage reveals a hidden weakness in some cancers

Researchers in the Chapman Group have discovered why cancer cells lacking a protein called ATM are particularly vulnerable to a class of cancer drugs known as PARP inhibitors, solving a scientific puzzle that has challenged researchers for nearly 20 years.

Professor Marella de Bruijn receives MRC Programme Award

Congratulation to Professor de Bruijn, who has been awarded funding from the UKRI Medical Research Council to investigate how the first blood stem cells formed in the embryo acquire their exceptional regenerative potential, with the aim of informing future stem cell therapies.

How body fat is stored across organs may reveal hidden health risks, study suggests

University of Oxford researchers have found that how fat accumulates in the body is just as important for identifying different health risks as a person’s overall weight.

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.